ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription

  1. Rozenn Riou
  2. Meriem Ladli
  3. Sabine Gerbal-Chaloin
  4. Pascale Bossard
  5. Angélique Gougelet
  6. Cécile Godard
  7. Robin Loesch
  8. Isabelle Lagoutte
  9. Franck Lager
  10. Julien Calderaro
  11. Alexandre Dos Santos
  12. Zhong Wang
  13. Frédérique Verdier
  14. Sabine Colnot  Is a corresponding author
  1. Institut National de la Santé et de la Recherche Médicale, France
  2. Assistance Publique Hôpitaux de Paris, France
  3. University of Michigan, United States

Abstract

Erythropoietin (EPO) is a key regulator of erythropoiesis. The embryonic liver is the main site of erythropoietin synthesis, after which the kidney takes over. The adult liver retains the ability to express EPO, and we discovered here new players of this transcription, distinct from the classical hypoxia-inducible factor pathway. In mice genetically-invalidated in hepatocytes for the chromatin remodeler Arid1a, and for Apc, the major silencer of Wnt pathway, chromatin was more accessible and histone marks turned into active ones at the Epo downstream enhancer. Activating β-catenin signaling increased binding of Tcf4/β-catenin complex and upregulated its enhancer function. The loss of Arid1a together with β-catenin signaling, resulted in cell-autonomous EPO transcription in mouse and human hepatocytes. In mice with Apc-Arid1a gene invalidations in single hepatocytes, Epo de novo synthesis led to its secretion, to splenic erythropoiesis and to dramatic erythrocytosis. Thus, we identified new hepatic EPO regulation mechanism stimulating erythropoiesis.

Data availability

Microarrays have been deposited in GEO database (GSE134553) and are publicly available.All data generated or analysed during this study are included in the manuscript and supporting files. Source data excel files have been provided for Figures 1, 2, 3, 4, 5, 7, 8, 1S1,1S3,3S1,5S1,5S2,7S1.

The following data sets were generated

Article and author information

Author details

  1. Rozenn Riou

    Centre de Recherche des Cordeliers UMRS1138, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Meriem Ladli

    Institut Cochin U1016, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Sabine Gerbal-Chaloin

    IRMB U1183, Institut National de la Santé et de la Recherche Médicale, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Pascale Bossard

    Institut Cochin U1016, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Angélique Gougelet

    Centre de Recherche des Cordeliers UMRS1138, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Cécile Godard

    Centre de Recherche des Cordeliers UMRS1138, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Robin Loesch

    Centre de Recherche des Cordeliers UMRS1138, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Isabelle Lagoutte

    Institut Cochin U1016, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Franck Lager

    Institut Cochin U1016, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Julien Calderaro

    Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Alexandre Dos Santos

    Paul Brousse University Hospital, Institut National de la Santé et de la Recherche Médicale, Villejuif, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Zhong Wang

    Department of Cardiac Surgery, University of Michigan, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8720-4609
  13. Frédérique Verdier

    Institut Cochin U1016, Institut National de la Santé et de la Recherche Médicale, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Sabine Colnot

    Centre de Recherche des Cordeliers UMRS1138, Institut National de la Santé et de la Recherche Médicale, Paris, France
    For correspondence
    sabine.colnot@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3949-9107

Funding

Institut National Du Cancer (Epigenetics and Liver Cancer)

  • Rozenn Riou
  • Angélique Gougelet
  • Cécile Godard
  • Julien Calderaro
  • Sabine Colnot

Ligue Contre le Cancer (Equipe Labellisée)

  • Rozenn Riou
  • Angélique Gougelet
  • Cécile Godard
  • Sabine Colnot

Agence Nationale de la Recherche (Labex Who Am I"; Idex "EpilivCan"")

  • Rozenn Riou
  • Angélique Gougelet
  • Cécile Godard
  • Sabine Colnot

Institut National Du Cancer (Chromaliv)

  • Rozenn Riou
  • Angélique Gougelet
  • Cécile Godard
  • Sabine Colnot

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Irwin Davidson, Institut de Génétique et de Biologie Moléculaire et Cellulaire, France

Ethics

Animal experimentation: This study was performed in strict accordance with the French government regulations. All of the animals were handled according to approved institutional animal care and use committee (Ethics Committee of Descartes University, Paris). The protocol was approved by the Ethics Committee of Descartes University, Paris (permit number APAFIS#14472). Every effort was made to minimize suffering.

Version history

  1. Received: November 12, 2019
  2. Accepted: October 20, 2020
  3. Accepted Manuscript published: October 21, 2020 (version 1)
  4. Version of Record published: November 4, 2020 (version 2)

Copyright

© 2020, Riou et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,392
    views
  • 204
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rozenn Riou
  2. Meriem Ladli
  3. Sabine Gerbal-Chaloin
  4. Pascale Bossard
  5. Angélique Gougelet
  6. Cécile Godard
  7. Robin Loesch
  8. Isabelle Lagoutte
  9. Franck Lager
  10. Julien Calderaro
  11. Alexandre Dos Santos
  12. Zhong Wang
  13. Frédérique Verdier
  14. Sabine Colnot
(2020)
ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription
eLife 9:e53550.
https://doi.org/10.7554/eLife.53550

Share this article

https://doi.org/10.7554/eLife.53550

Further reading

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression
    Ramona Weber, Chung-Te Chang
    Research Article

    Recent findings indicate that the translation elongation rate influences mRNA stability. One of the factors that has been implicated in this link between mRNA decay and translation speed is the yeast DEAD-box helicase Dhh1p. Here, we demonstrated that the human ortholog of Dhh1p, DDX6, triggers the deadenylation-dependent decay of inefficiently translated mRNAs in human cells. DDX6 interacts with the ribosome through the Phe-Asp-Phe (FDF) motif in its RecA2 domain. Furthermore, RecA2-mediated interactions and ATPase activity are both required for DDX6 to destabilize inefficiently translated mRNAs. Using ribosome profiling and RNA sequencing, we identified two classes of endogenous mRNAs that are regulated in a DDX6-dependent manner. The identified targets are either translationally regulated or regulated at the steady-state-level and either exhibit signatures of poor overall translation or of locally reduced ribosome translocation rates. Transferring the identified sequence stretches into a reporter mRNA caused translation- and DDX6-dependent degradation of the reporter mRNA. In summary, these results identify DDX6 as a crucial regulator of mRNA translation and decay triggered by slow ribosome movement and provide insights into the mechanism by which DDX6 destabilizes inefficiently translated mRNAs.

    1. Chromosomes and Gene Expression
    Marwan Anoud, Emmanuelle Delagoutte ... Jean-Paul Concordet
    Research Article

    Tardigrades are microscopic animals renowned for their ability to withstand extreme conditions, including high doses of ionizing radiation (IR). To better understand their radio-resistance, we first characterized induction and repair of DNA double- and single-strand breaks after exposure to IR in the model species Hypsibius exemplaris. Importantly, we found that the rate of single-strand breaks induced was roughly equivalent to that in human cells, suggesting that DNA repair plays a predominant role in tardigrades’ radio-resistance. To identify novel tardigrade-specific genes involved, we next conducted a comparative transcriptomics analysis across three different species. In all three species, many DNA repair genes were among the most strongly overexpressed genes alongside a novel tardigrade-specific gene, which we named Tardigrade DNA damage Response 1 (TDR1). We found that TDR1 protein interacts with DNA and forms aggregates at high concentration suggesting it may condensate DNA and preserve chromosome organization until DNA repair is accomplished. Remarkably, when expressed in human cells, TDR1 improved resistance to Bleomycin, a radiomimetic drug. Based on these findings, we propose that TDR1 is a novel tardigrade-specific gene conferring resistance to IR. Our study sheds light on mechanisms of DNA repair helping cope with high levels of DNA damage inflicted by IR.